NCI | Technology Transfer

KINASE INHIBITORS

Read more about KINASE INHIBITORS

Patent Cooperation Treaty
PCT/US2024/038376
Filed on 2024-07-17

METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF

Read more about METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF

China
202410809055.0
Filed on 2024-06-21

T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME

Read more about T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME

Patent Cooperation Treaty
PCT/US2024/030357
Filed on 2024-05-21

Anti-Viral Compositions And Methods Of Making And Using

Read more about Anti-Viral Compositions And Methods Of Making And Using

European Patent
20862862.8
Filed on 2022-04-11

Anti-Viral Compositions And Methods Of Making And Using

Read more about Anti-Viral Compositions And Methods Of Making And Using

Australia
2020346819
Filed on 2022-03-18

Anti-Viral Compositions And Methods Of Making And Using

Read more about Anti-Viral Compositions And Methods Of Making And Using

Canada
3150731
Filed on 2022-03-09

Glypican 2 As A Cancer Marker And Therapeutic Target

Read more about Glypican 2 As A Cancer Marker And Therapeutic Target

Serbia
16864859.0
Filed on 2018-05-18

Glypican 2 As A Cancer Marker And Therapeutic Target

Read more about Glypican 2 As A Cancer Marker And Therapeutic Target

Malta
16864859.0
Filed on 2018-05-18

Glypican 2 As A Cancer Marker And Therapeutic Target

Read more about Glypican 2 As A Cancer Marker And Therapeutic Target

North Macedonia
16864859.0
Filed on 2018-05-18

Glypican 2 As A Cancer Marker And Therapeutic Target

Read more about Glypican 2 As A Cancer Marker And Therapeutic Target

Monaco
16864859.0
Filed on 2018-05-18

Subscribe to NCI